SBI Healthcare Opportunities Fund - IDCW - Regular Plan

  • Previous Nav

  • Net Change on 03-03-2025

  • PersonalFN Rating

  • Assets (Cr.)

  • Expense Ratio

Fund Overview IDCW | Regular Plan

  • Fund House

  • Launch Date

  • Benchmark

  • Minimum Investment (₹)

  • Minimum Addl Investment (₹)

  • Exit Load (%)

  • Minimum SIP Investment (₹)

  • Minimum STP Investment (₹)

  • Minimum SWP Investment (₹)

  • 52 Week Low Nav (₹)

  • 52 Week Low Nav Date

  • 52 Week High Nav (₹)

  • 52 Week High Nav Date

Fund Objective

To provide the investors with the opportunity of long-term capital appreciation by investing in a diversified portfolio of equity and equity related securities in Healthcare space.

Fund Performance

Scheme Name 1-Month Return (%) 3-Month Return (%) 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Since Inception
SBI Healthcare Opportunities Fund - Regular Plan - Income Distribution cum Capital Withdrawal Option (IDCW) -3.61 -7.72 10.37 21.46 24.92 16.44
BSE Health Care - TRI -8.34 -13.32 10.29 19.20 23.23 15.06
BSE SENSEX - TRI -5.22 -9.47 0.23 11.27 14.99 13.21

Returns upto 1 year is Absolute, and above 1 year are Compounded Annualised

Peer Fund Comparison

Scheme Name Launch Date Ratings 1-Year Return (%) 3-Year Return (%) 5-Year Return (%) Expense Ratio (%) Assets (Cr.)
SBI Healthcare Opportunities Fund - Regular Plan - Income Distribution cum Capital Withdrawal Option (IDCW) Jul 03, 1999 10.37 21.46 24.92 1.94 3,521.93
NIPPON INDIA PHARMA FUND - IDCW Option Jun 05, 2004 4.92 17.37 23.47 1.82 8,160.74
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - IDCW Option Jul 13, 2018 12.23 21.60 26.45 1.93 4,917.81
DSP Healthcare Fund - Regular Plan - IDCW Nov 30, 2018 10.01 19.24 24.88 1.91 3,197.52
Mirae Asset Healthcare Fund Regular IDCW Jul 02, 2018 8.24 16.03 23.93 1.94 2,652.24
TATA India Pharma & Health Care Fund Regular Plan - Payout of Income Distribution cum capital withdrawal option Dec 28, 2015 5.77 17.47 22.50 2.16 1,211.73

Fund Holdings as on 31-January-2025

  • Sun Pharmaceutical Industries Ltd.

  • Max Healthcare Institute Ltd.

  • Divi's Laboratories Ltd.

  • Cipla Ltd.

  • Lupin Ltd.

  • Lonza Group

  • Mankind Pharma Ltd.

  • Jupiter Life Line Hospitals Ltd.

  • Krishna Institute of Medical Sciences Ltd.

  • Ami Organics Ltd.

  • Polymedicure Ltd.

  • Aether Industries Ltd.

  • Fortis Healthcare Ltd.

  • Aster DM Healthcare Ltd.

  • Laurus Labs Ltd.

  • Torrent Pharmaceuticals Ltd.

  • Abbott India Ltd.

  • Rainbow Children's Medicare Ltd.

  • Aurobindo Pharma Ltd.

  • Gland Pharma Ltd.

  • Alkem Laboratories Ltd.

  • Biocon Ltd.

  • Vijaya Diagnostic Centre Ltd.

  • TREPS

  • Suven Pharmaceuticals Ltd.

  • Akums Drugs & Pharmaceuticals Ltd.

  • Pfizer Ltd.

  • Gufic Biosciences Ltd.

  • Concord Biotech Ltd.

  • Sanofi Consumer Healthcare India Ltd.

  • 182 DAY T-BILL 05.06.25

  • Net Receivable / Payable

View More
  • Pharmaceuticals & Drugs

  • Hospital & Healthcare Services

  • Miscellaneous

  • Medical Equipment/Supplies/Accessories

  • Chemicals

View More

Fund Manager

Most Recent Dividend

  • 16/03/2018

  • 30/01/2015

  • 04/01/2005

  • 06/09/2004

  • 22/09/2003

  • Cash

  • Equity

  • Sovereign

View More

About SBI Healthcare Opportunities Fund

Scheme Analysis

SBI Healthcare Opportunities Fund is a Equity - Sectoral Fund - Pharma & Health Care fund and belongs to SBI Mutual Fund. It was launched on 03-Jul-1999 and currently has an AUM of ₹3,521.93 crore. SBI Healthcare Opportunities Fund is benchmarked against BSE Health Care - TRI as primary index and BSE SENSEX - TRI as secondary index.

The NAV of SBI Healthcare Opportunities Fund ended up ₹0.9(0.38%)yesterday to ₹242.0815.

Among its top 3 holdings the fund has exposure to Sun Pharmaceutical Industries Ltd., and

The SBI Healthcare Opportunities Fund is managed by Tanmaya Desai and Pradeep Kesavan.

Fund House Contact

9th Floor, Crescenzo, C - 38 & 39 G Block, BKC, Bandra (East) Mumbai - 400 051

022 - 61793537
022 - 22189663
www.sbimf.com